2-149214558-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_177964.5(LYPD6B):​c.472T>G​(p.Cys158Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

LYPD6B
NM_177964.5 missense

Scores

10
8
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.58
Variant links:
Genes affected
LYPD6B (HGNC:27018): (LY6/PLAUR domain containing 6B) Enables acetylcholine receptor regulator activity. Predicted to be located in extracellular region and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.888

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LYPD6BNM_177964.5 linkuse as main transcriptc.472T>G p.Cys158Gly missense_variant 7/7 ENST00000409642.8 NP_808879.2 Q8NI32-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LYPD6BENST00000409642.8 linkuse as main transcriptc.472T>G p.Cys158Gly missense_variant 7/71 NM_177964.5 ENSP00000387077.3 Q8NI32-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 22, 2024The c.472T>G (p.C158G) alteration is located in exon 7 (coding exon 6) of the LYPD6B gene. This alteration results from a T to G substitution at nucleotide position 472, causing the cysteine (C) at amino acid position 158 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
30
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.48
.;T;T;T
Eigen
Pathogenic
0.73
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.96
D;.;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.89
D;D;D;D
MetaSVM
Uncertain
0.25
D
MutationAssessor
Pathogenic
3.0
.;M;M;.
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-11
D;D;D;.
REVEL
Pathogenic
0.81
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Uncertain
0.012
D;D;D;D
Polyphen
1.0
D;D;D;.
Vest4
0.94
MutPred
0.57
.;Gain of sheet (P = 0.0043);Gain of sheet (P = 0.0043);Gain of sheet (P = 0.0043);
MVP
0.67
MPC
0.74
ClinPred
1.0
D
GERP RS
5.7
Varity_R
0.96
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-150071072; API